Approximately 5% of the world-wide population is affected by autoimmune diseases.
Overall, autoimmune diseases are still difficult to treat, impose a high burden on patients …

An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

Background Pemphigus vulgaris and pemphigus foliaceus are potentially life‐threatening
autoimmune disorders triggered by IgG autoantibodies against mucosal and epidermal …

Background Paraneoplastic pemphigus (PNP), also called paraneoplastic autoimmune
multiorgan syndrome (PAMS), is a rare autoimmune disease with mucocutaneous and multi …

Autoimmune bullous dermatoses (AIBD) are a heterogeneous group of about a dozen
diseases characterized clinically by erosions and blisters and immunopathologically by …

Pemphigus und Pemphigoid sind seltene Autoimmunkrankheiten der Haut mit potenziell
lebensbedrohlichem Verlauf. Autoantikörper gegen epidermale und junktionale …

Background Sex and gender have increasingly been recognized as significant risk factors
for many diseases, including dermatological conditions. Historically, sex and gender have …

Pemphigus vulgaris (PV) is an acquired autoimmune blistering disease characterized by the
production of autoantibodies targeting desmosomal cadherins, primarily desmoglein 1 and …

Pemphigus, an autoimmune intraepidermal bullous disease group with roughly eight distinct
forms, includes pemphigus vulgaris (PV) and pemphigus foliaceus (PF) as its predominant …

Antagonism of the neonatal Fc receptor (FcRn) by efgartigimod has been studied in several
autoimmune diseases mediated by immunoglobulin G (IgG) as a therapeutic approach to …